Nitric-oxide-induced reoxygenation injury in the cyanotic immature heart is prevented by controlling oxygen content during initial reoxygenation

Angiology

Volumn 48, Issue 3, 1997, Pages 189-202

  Ihnken, Kai ^a   Morita, Kiyozo ^b   Buckberg, Gerald D ^b   Winkelmann, Bernhard ^a   Schmitt, Matthias ^a   Ignarro, Louis J ^b   Sherman, M P ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; NITRIC OXIDE; OXYGEN; OXYGEN RADICAL; PEROXYNITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYANOTIC HEART DISEASE; CYTOTOXICITY; HEART DEVELOPMENT; HEART INJURY; HYPEROXIA; NONHUMAN; REOXYGENATION; REPERFUSION INJURY; SWINE;

EID: 0030965650     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800301     Document Type: Article

References (54)

1. Borow KM, Keane JF, Castaneda AR, et al: Systemic ventricular function in patients with tetralogy of Fallot, ventricular septal defect and transposition of the great arteries repaired during infancy. Circulation 64:878-885, 1981.
2. Kirklin JK, Blackstone EH, Kirklin JW, et al: Intra-cardiac surgery in infants under age 3 months: Incremental risk factors for hospital mortality. Am J Cardiol 48:500-506, 1981.
3. Fujiwara T, Kurtts T, Andersen W, et al: Myocardial protection in cyanotic neonatal lambs. J Thorac Cardiovasc Surg 96:700-710, 1988.
4. Ihnken K, Morita K, Buckberg GD, et al: Studies of reoxygenation injury in the cyanotic immature heart. I. Evidence for reoxygenation damage after reintroduction of molecular oxygen after hypoxia. J Thorac Cardiovasc Surg 110:891-901, 1995.
5. Matheis G, Sherman MP, Buckberg GD, et al: Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 262:H616-H620, 1992.
6. Matheis G, Tixier DB, Buckberg GD, et al: Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals supported by cardiopulmonary bypass: Prevention by intravenous metabolic pretreatment. J Thorac Cardiovasc Surg 105:513-519, 1993.
7. Silverman NA, Kohler J, Levitsky S, et al: Chronic hypoxemia depresses global ventricular function and predisposes to the depletion of high-energy phosphates during cardioplegic arrest: Implications for surgical repair of cyanotic congenital heart defects. Ann Thorac Surg 37:304-308, 1984.
8. Del Nido RJ, Mickle DAG, Wilson GJ, et al: Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 95:223-229, 1988.
9. Deneke SM, Fanburg BL: Normobaric oxygen toxicity of the lung. N Engl J Med 303:76-86, 1980.
10. Gauduel Y, Menasche P, Duvelleroy M: Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: Relationship with oxygen-induced lipid peroxidation. General Physiological Biophysics 8:327-340, 1989.
11. Hearse DJ, Humphrey SM, Bullock GR: The oxygen paradox and the calcium paradox: Two facets of the same problem? J Mol Cell Cardiol 10:641-668, 1978.
12. Littauer A, De Groot H: Release of reactive oxygen by hepatocytes on reoxygenation: Three phases and role of mitochondria. Am J Physiol 262:G1015-G1020, 1992.
13. Schluter KD, Schwartz P, Siegmund B, et al: Prevention of the oxygen paradox in hypoxic-reoxygenated hearts. Am J Physiol 261:H416-H423, 1991.
14. Brady AJB, Poole-Wilson P, Harding SE, et al: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963-H1966, 1992.
15. Cavarocchi NC, England MD, Schaff HV, et al: Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation 74 (suppl III):IIM30-133, 1986.
16. Frank L, Massaro D: Oxygen toxicity. Am J Med 69:117-126, 1980.
17. Teoh KH, Mickle DAG, Weisel RD, et al: Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thoracic Cardiovasc Surg 104:159-64, 1992.
18. Del Nido PJ, Mickle DAG, Wilson GJ, et al: Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. Circulation 76 (suppl V):V174-V179, 1987.
19. Hirschl RB, Heiss KF, Bartlett RH: Severe myocardial dysfunction during extracorporeal membrane oxygenation. J Pediatric Surg 27:48-53, 1992.
20. Martin GR, Short BL, Abbott C, et al: Cardiac stun in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 101:607-611, 1991.
21. Bolli R, Jeroudi MO, Patel BS: Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Si USA 86:4695-4699, 1989.
22. Davies MJ: Applications of electron spin resonance spectroscopy to the identification of radicals produced during lipid peroxidation. Chemistry and Physics of Lipids 44:149-173, 1987.
23. Alien BS, Okamoto F, Buckberg GD, et al: Studies of controlled reperfusion after ischemia, XII. Effects of "duration" of reperfusate administration versus reperfusate "dose" on regional functional, biochemical, and histochemical recovery. J Thoracic Cardiovasc Surg 92:594-604, 1986.
24. Rengasamy A, Johns RA: Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. J Pharmacol Exp Ther 259:310-316, 1991.
25. Follette DM, Fey K, Buckberg GD, et al: Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thoracic Cardiovasc Surg 82:221-238, 1981.
26. Rosenkranz ER, Okamoto F, Buckberg GD, et al: Safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts. J Thoracic Cardiovasc Surg 88:402-410, 1984.
27. Vinten-Johansen J, Buckberg GD, Okamoto F, et al: Studies of controlled reperfusion after ischemia. V. Superiority of surgical versus medical reperfusion after regional ischemia. J Thoracic Cardiovasc Surg 92:525-534, 1986.
28. Hecker M, Mitchell JA, Swierkosz TA, et al: Inhibition by L-glutamine of the release of endothelium-derived relaxing factor from cultured endothelial cells. Br J Pharmacol 101:237-239, 1990.
29. Sher PK, Hu S: Neuroprotective effect of graded reoxygenation following chronic hypoxia in neuronal cell cultures. Neuroscience 47:979-984, 1992.
30. Lesnefsky EJ, Fennessey PM, Van Benthuysen KM, et al: Superoxide dismutase decreases early reperfusion release of conjugated dienes following regional canine ischemia. Basic Res Cardiol 84:191-196, 1989.
31. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560, 1990.
32. Bush PA, Gonzalez NE, Griscavage JM, et al: Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Com 185:960-966, 1992.
33. Godin DV, Ko KM, Garnett ME: Altered antioxidant status in the ischemic/reperfused rabbit myocardium: Effects of allopurinol. Can J Cardiol 5:365-371, 1989.
34. Sagawa K, Manghan WL, Suga H, et al: Cardiac Contraction and Pressure-Volume Relationship. New York: Oxford University Press; 1988, pp 56-61, 110-119.
35. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci 87:1620-1624,1990.
36. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite oxidation of sulfhydrils. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244-4250, 1991.
37. Lazar HL, Buckberg GD, Manganaro AM, et al: Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 80:350-359, 1980.
38. Kofsky E, Julia P, Buckberg GD, et al: Studies of myocardial protection in the immature heart. V. Safety of prolonged aortic clamping with hypocalcemic glutamate/aspartate blood cardioplegia. J Thorac Cardiovasc Surg 101:33-43, 1991.
39. Rosenkranz ER, Okamoto F, Buckberg GD, et al: Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamateblood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg 91:428-435, 1986.
40. Kanter KR, Glower DD, Schaff HV, et al: Mechanism of defective oxygen extraction following global ischemia. J Surg Res 30:482-488, 1981.
41. Grinwald PM, Brosnahan C: Sodium imbalance as a cause of calcium overload in post-hypoxic reoxygenation injury. J Mol Cell Cardiol 19:487-495, 1987.
42. Peng CF, Kane JJ, Murphy ML, et al: Abnormal mitochondrial oxidative phosphorylation of ischemic myocardium reversed by Ca chelating agent, J Mol Cell Cardiol 9:897-908, 1977.
43. Kukreja RC, Kontos HA, Hess ML, et al: PGH synthase and lipoxygenase generate Superoxide in the presence of NADH or NADPH. Circ Res 59:612-619, 1986.
44. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-134, 1991.
45. Taegtmeyer H: Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscle. Circ Res 43:808-815, 1978.
46. Bogie RG, Coade SB, Moncada S, et al: Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Comms 180:926-932, 1991.
47. Sweiry JH, Munoz M, Mann GE: Cis-inhibition and trans-stimulation of cationic amino acid transport in the perfused rat pancreas. Am J Physiol 261:C506-C514, 1991.
48. Kofsky ER, Julia P, Buckberg GD: Overdose reperfusion of blood cardioplegic solution. A preventable cause of postischemic myocardial depression. J Thoracic Cardiovasc Surg 101:275-283, 1991.
49. Boveris A, Chance B: The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134:707-716, 1973.
50. Dhaliwal H, Kirshenbaum LA, Randhawa AK, et al: Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol 261:H632-H638, 1991.
51. Guarnieri C, Flamigni F, Caldarera CM: Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart. J Mol Cell Cardiol 12:797-808, 1980.
52. Tribble DL, Jones DP: Oxygen dependence of oxidative stress. Rate of NADPH supply for maintaining the GSH pool during hypoxia. Biochem Pharmacol 39:729-736, 1990.
53. Rudolph W: Myocardial metabolism in cyanotic congenital heart disease. Cardiology 56:209-215, 1972.
54. Li RK, Mickle DAG, Weisel RD, et al: Effect of oxygen tension on the antioxidant enzyme activities of Tetralogy of Fallot ventricular myocytes. J Mol Cell Cardiol 21:567-575, 1989.